Considerations for the treatment of 102 neuropsychiatric patients with reserpine.
D004565:Electroconvulsive Therapy; D001523:Mental Disorders / Q000628:therapy*; D011612:Psychosurgery; D011613:Psychotherapy; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*
D046948:Secologanin Tryptamine Alkaloids
MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use
Considerazioni sul trattamento di 102 pazienti neuropsichiatrici con reserpina.